Column1

STATEMENT OF FINANCIAL POSITION

Column2

Merck
ASSETS
Current Assets
Cash and Cash Equivalent
Trade Receivables:
Third Parties
Related Parties
Other receivables
Other current financial assets
Inventories
Prepaid Value Added Tax
Prepaid expenses
Prepaid taxes
Advances
Other current assets
TOTAL Current Assets

Rp
Rp
Rp
Rp
Rp
Rp
Rp
Rp
Rp
Rp
Rp

161,472,425,000
57,181,000
10,058,588,000
161,124,628,000
9,562,570,000
573,009,000
483,679,971,000

Non Current-Assets
Advances for purchases of fixed assets
Investment in associate
Other non-current financial asset
Fixed assets/PPE
Refundable taxes
Intangible assets
Deferred tax assets
Prepaid expenses
Other non-current assets
Total Non Current Assets
Total ASSETS

Rp
Rp
Rp
Rp
Rp
Rp
Rp
Rp
Rp
Rp
Rp

16,688,580,000
110,784,138,000
12,425,640,000
1,072,328,000
13,877,076,000
1,350,453,000
1,768,632,000
157,966,847,000
641,646,818,000

LIABILITIES
Current Liabilities
Short-term bank loans
Trade payables

Rp

140,831,570,000

Rp

Third parties
Related party

Rp
Rp

65,617,327,000
3,481,657,000

Third parties
Related party

Rp
Rp
Rp
Rp
Rp
Rp
Rp

4,696,995,000
3,626,932,000

Other payables

Accrued expenses
Income taxes payable
Taxes payable
Short-term employee benefits liabilities
Other taxes payable

Current maturities of finance lease payable

Other current liabilities
Total Current Liabilities

Rp
Rp
Rp

55,012,984,000
132,435,895,000

Rp

Rp

32,572,811,000

Rp
Rp
Rp

3,094,830,000
35,667,641,000
168,103,536,000

EQUITY
Share Capital
Treasury Stock
Additional paid-in capital
Retained earnings

Rp
Rp
Rp
Rp

22,400,000,000
17,561,517,000
433,581,765,000

Appropriated
Unappropriated
Other comprehensive income/loss
NCI
Total EQUITY
TOTAL LIABILITIES AND EQUITY

Rp
Rp
Rp
Rp

Non Current Liabilities

Long-term bank loan
Deferred tax liabilities, net
Long-term liabilities for employees benefits
Long-term maturities of finance lease payable
Other non-current liabilities
Total Non Current Liabilities
Total LIABILITIES

473,543,282,000
641,646,818,000

STATEMENT OF FINANCIAL POSITION

Merck
ASSETS
Current Assets
Cash and Cash Equivalent
Trade Receivables:
Third Parties
Related Parties
Other receivables
Other current financial assets
Inventories
Prepaid Value Added Tax
Prepaid expenses
Prepaid taxes
Advances
Other current assets
TOTAL Current Assets
Non Current-Assets
Advances for purchases of fixed assets

22%
25%
0.009%
2%
0%
25%

Investment in associate
Other non-current financial asset
Fixed assets/PPE
Refundable taxes
Intangible assets
Deferred tax assets
Prepaid expenses
Other non-current assets
Total Non Current Assets
Total ASSETS
LIABILITIES
Current Liabilities
Short-term bank loans
Trade payables
Third parties
Related party
Other payables
Third parties
Related party
Accrued expenses
Income taxes payable
Taxes payable
Short-term employee benefits liabilities
Other taxes payable
Current maturities of finance lease payable
Other current liabilities
Total Current Liabilities
Non Current Liabilities
Long-term bank loan
Deferred tax liabilities, net
Long-term liabilities for employees benefits
Long-term maturities of finance lease payable
Other non-current liabilities
Total Non Current Liabilities
Total LIABILITIES
EQUITY
Share Capital
Treasury Stock
Additional paid-in capital
Retained earnings
Appropriated
Unappropriated
Other comprehensive income/loss
NCI
Total EQUITY

TOTAL LIABILITIES AND EQUITY

Column3

Darya Varia

Kalbe Farma

Rp

Column4

2,718,619,232,764 Rp

Rp
Rp
Rp
Rp
Rp
Rp
Rp
Rp
Rp
Rp
Rp

2,337,444,304,540
17,335,467,379
79,301,987,108
155,753,502,796
3,003,149,535,671
31,631,064,733
66,672,277,410
338,584,236,301
8,748,491,608,702

Rp
Rp
Rp
Rp
Rp
Rp
Rp
Rp
Rp
Rp
Rp

45,890,342,781
11,760,000,000
3,938,494,051,483
83,631,207,773
415,279,754,800
106,339,190,223
346,531,225,677
4,947,925,772,737
13,696,417,381,439

Rp
Rp
Rp
Rp
Rp
Rp
Rp
Rp
Rp
Rp
Rp

Rp
Rp
Rp
Rp
Rp
Rp
Rp
Rp
Rp

422,259,085,000
365,905,424,000
32,605,103,000
6,426,818,000
198,658,033,000
12,862,185,000
935,963,000
4,177,423,000
1,043,830,034,000

###
3,499,600,000
5,350,120,000
258,265,183,000
13,467,287,000
15,031,236,000
33,578,619,000
###
3,256,158,000
332,448,203,000
1,376,278,237,000

Rp

266,148,059,414 Rp

Rp
Rp

1,024,170,082,622 Rp
44,495,441,420 Rp

49,399,641,000
3,259,367,000

Rp
Rp
Rp
Rp
Rp
Rp
Rp

391,108,233,500
408,242,363,125
197,459,298,266
32,427,710,263
-

Rp
Rp
Rp
Rp

###
171,128,034,000
###
12,035,879,000
28,547,547,000
###

Rp

1,829,302,253 Rp
Rp
2,365,880,490,863 Rp

31,927,650,000
296,298,118,000

Rp
Rp

127,727,051,924 Rp
6,602,342,000
254,715,638,636 Rp
3,205,872,747 Rp
Rp
392,250,905,307 Rp
2,758,131,396,170 Rp

Rp
Rp
Rp

468,751,221,100 Rp
- Rp
(34,118,673,814) Rp

Rp

Rp
Rp
Rp
Rp

Rp
Rp
Rp
Rp
Rp
Rp

134,314,355,465
9,872,083,279,142
1,880,779,565
23,315,537,863
10,466,226,499,321
13,224,357,895,491

Kalbe Farma

Rp
Rp
Rp
Rp
Rp
Rp

106,462,785,000
106,462,785,000
402,760,903,000

280,000,000,000
(8,560,945,000)
77,828,471,000
45,000,000,000
597,829,395,000
(18,579,587,000)
973,517,334,000
1,376,278,237,000

Darya Varia

STATEMENT OF FINANCIAL POSITION

Merck
ASSETS
Current Assets
Cash and Cash Equivalent
Trade Receivables:
Third Parties
Related Parties
Other receivables
Other current financial assets
Inventories
Prepaid Value Added Tax
Prepaid expenses
Prepaid taxes
Advances
Other current assets
TOTAL Current Assets
Non Current-Assets
Advances for purchases of fixed assets
Investment in associate
Other non-current financial asset
Fixed assets/PPE
Refundable taxes
Intangible assets
Deferred tax assets
Prepaid expenses
Other non-current assets
Total Non Current Assets
Total ASSETS
LIABILITIES
Current Liabilities
Short-term bank loans
Trade payables
Third parties
Related party
Other payables
Third parties
Related party
Accrued expenses
Income taxes payable
Taxes payable

Short-term employee benefits liabilities

Other taxes payable
Current maturities of finance lease payable
Other current liabilities
Total Current Liabilities
Non Current Liabilities
Long-term bank loan
Deferred tax liabilities, net
Long-term liabilities for employees benefits
Long-term maturities of finance lease payable
Other non-current liabilities
Total Non Current Liabilities
Total LIABILITIES
EQUITY
Share Capital
Treasury Stock
Additional paid-in capital
Retained earnings
Appropriated
Unappropriated
Other comprehensive income/loss
NCI
Total EQUITY
TOTAL LIABILITIES AND EQUITY

Kalbe Farma

Darya Varia